Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SZC for Hyperkalemia After Parathyroidectomy
NCT05382988Phase 3Completed
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Nov 2016
- Primary completion
- Dec 2021
- Modality
- DNA Intercalators/Alkylators
01
Overview
Phase 3, randomised, open-label trial of sodium zirconium cyclosilicate in hyperkalemia (2 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoint: Change of serum potassium levels at 15 hours. Started Nov 2016; status: completed.
02
Drugs
sodium zirconium cyclosilicate
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on NCT05382988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05382988.